* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download The spectrum of human diseases
BRCA mutation wikipedia , lookup
Human genome wikipedia , lookup
Tay–Sachs disease wikipedia , lookup
Non-coding DNA wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Gene therapy wikipedia , lookup
Gene expression profiling wikipedia , lookup
Y chromosome wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Human genetic variation wikipedia , lookup
Genetic engineering wikipedia , lookup
Medical genetics wikipedia , lookup
Dominance (genetics) wikipedia , lookup
Saethre–Chotzen syndrome wikipedia , lookup
History of genetic engineering wikipedia , lookup
Skewed X-inactivation wikipedia , lookup
Neocentromere wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Population genetics wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Genome editing wikipedia , lookup
Gene expression programming wikipedia , lookup
Genome-wide association study wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
X-inactivation wikipedia , lookup
Frameshift mutation wikipedia , lookup
Genomic imprinting wikipedia , lookup
Genome evolution wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Designer baby wikipedia , lookup
Oncogenomics wikipedia , lookup
Point mutation wikipedia , lookup
Quantitative trait locus wikipedia , lookup
Public health genomics wikipedia , lookup
Molecular medicine - 2 Example of identifying a monogenic condition by positional cloning cystic fibrosis caused by mutations in the CF gene Most common severe autosomal recessive condition among Caucasians. About 5% of white Caucasians of European descent are asymptomatic carriers. Frequency of 1 / 2,500 affecting approximately 30,000 people In 1985, CF locus was localized on the long arm of chromosome 7 In 1989, the gene implicated in CF was isolated (Kerem 1989; Riordan 1989; Rommens 1989). Pathology Woe to that child which when kissed on the forehead tastes salty. He is bewitched and soon must die CF gene encodes a cystic fibrosis transmembrane conductance regulator CFTR is a Cl- channel (defects result in either a decrease in its Cltransport capacity or its level of cell surface expression) epithelial Cltransport Cltransport rate determined by activation of CFTR which in turn depends on its state of phosphorylation. Acts as a regulator of other channels & transporters e.g CFTR mediates cAMP regulation of amiloride sensitive epithelial Na+ channels (EnaCs) CFTR function http://www.infobiogen.fr/services/chromcancer/IntroItems/Images/CFTREnglFig2.jpg F508 70% of CF patients show a specific deletion F508 deletion in exon 10 (F): NBD-1 domain CFTR misfolding in the ER and targeted for proteosome degradation Mapping of CFTR 1985 gene for CF linked to enzyme paraoxanase (PON) PON mapped to chromosome 7 and CF mapped to 7q31-32 (random DNA marker D7S15) 2 flanking markers established (~2x106bp apart) proximal MET oncogene and distal D7S8 extensive mapping and characterisation around the candidate region by chromosome walking, chromosome jumping and microdissection (~300kbp cloned) CFTR candidate region Mapping of CFTR 2 new markers identified – KM19 and XV2c – which showed strong linkage disequilibrium 5’ end of gene located Bovine equivalent of candidate gene isolated from genomic library 7 cDNA libraries screened with human clone. 1 cDNA clone identified. Northern blots show 6.5 kb mRNA Rest of the gene obtained by screening and PCR 1989 CFTR gene eventually isolated by mutation screening linkage disequilibrium Alleles at 2 or more loci that show a nonrandom association are said to be in linkage disequilibrium. Allelic association in cystic fibrosis Marker alleles X1,K1 X1,K2 X2,K1 X2,K2 CF chromosomes 3 147 8 8 Normal chromosomes 49 19 70 25 RFLP markers XV2C (X1,X2) and KM19 (K1,K2) Letter to Dr. Collins. Courtesy of the National Human Genome Research Institute The spectrum of human diseases Cystic fibrosis thalassemia <5% cancer Huntington’s Mapping complex loci PAF – population attributable factor: Fraction of the disease that would be eliminated if the risk factor were removed High PAF for single gene conditions (>50% for CF) Low PAF for complex disease (< 5% for Alzheimer’s) Identifying genes involved in complex diseases Perform family, twin or adoption studies - check for genetic component Segregation analysis - estimate type and frequency of susceptibility alleles Linkage analysis - map susceptibility loci Population association - identify candidate region Identify DNA sequence variants conferring susceptibility Linkage versus Assocciation Association studies compare the allele frequency of a polymorphic marker, or a set of markers, in unrelated patients (cases) and healthy controls to identify markers that differ significantly between the two groups. Used to identify common modestrisk disease variants Higher density of markers needed e.g. HapMap uses association data Linkage analyses search for regions of the genome with a higher-than-expected number of shared alleles among affected individuals within a family. Used to identify rare high-risk disease alleles <500 markers needed for initial genome scan Direct versus indirect association analysis. a, In direct association analysis,all functional variants (red arrows) are catalogued and tested for association with disease. A GeneSNPs image of the CSF2 gene is shown. Genomic features are shown as boxes along the horizontal axis (for example, blue boxes indicate exons). Polymorphisms are shown as vertical bars below the axis, with the length of the line indicating allele frequency and colour indicating context (for example, red indicates coding SNPs that change amino acids). b, For indirect association analysis, all common SNPs are tested for function by assaying a subset of tagSNPs in each gene (yellow arrows), such that all unassayed SNPs (green arrows) are correlated with one or more tagSNPs. Effects at unassayed SNPs (green arrows) would be detected through linkage disequilibrium with tagSNPs. Images adapted from GeneSNPs (http://www.genome.utah.edu/genesnps). Haplotype Map (HapMap) • Haplotype: specific combination of 2 or more DNA marker alleles situated close together on the same chromosome (cis markers). E.g. SNPs • HapMap - catalog of common genetic variants in populations • International HapMap Project - identify common haplotypes in four populations with African, Asian, and European ancestry • provide information to link genetic variants to the risk of disease Ancient disease loci are associated with haplotypes • Start with population genetically isolated for a long time such as Icelanders or Amish • Collect DNA samples from subgroup with disease • Also collect from equal number of people without disease • Genotype each individual in subgroups for haplotypes throughout entire genome • Look for association between haplotype and disease phenotype • Association represents linkage disequilibrium • If successful, provides high resolution to narrow parts of chromosomes Series of closely linked mutations accumulate over time in the surviving generation derived from a common ancestor Haplotype analysis provides high resolution gene mapping Why is it still so difficult? Genetic heterogeneity Mutations at more than one locus cause same phenotype e.g. thalassemias – Caused by mutations in either the a or b-globin genes. – Linkage analysis studies therefore always combine data from multiple families Variable expressivity - Expression of a mutant trait differs from person to person • Phenocopy – Disease phenotype is not caused by any inherited predisposing mutation – e.g. BRCA1 mutations • 33% of women who do not carry BRCA1 mutation develop breast cancer by age 55 Incomplete penetrance – when a mutant genotype does not always cause a mutant phenotype • No environmental factor associated with likelihood of breast cancer • Positional cloning identified BRCA1 as one gene causing breast cancer. – Only 66% of women who carry BRCA1 mutation develop breast cancer by age 55 • Incomplete penetrance hampers linkage mapping and positional cloning – Solution – exclude all nondisease individuals form analysis – Requires many more families for study • Polygenic inheritance – Two or more genes interact in the expression of phenotype • QTLs, or quantitative trait loci – Unlimited number of transmission patterns for QTLs » Discrete traits – penetrance may increase with number of mutant loci » Expressivity may vary with number of loci – Many other factors complicate analysis » Some mutant genes may have large effect » Mutations at some loci may be recessive while others are dominant or codominant Polygenic inheritance E.g heart attack or high cholesterol levels Sudden cardiac death (SCD) Breast cancer Common condition – familial or sporadic forms Although a genetic basis for familial BC identified, the causes of sporadic disease still unknown Mutations in 2 loci account for 20-25% of early onset (<45 years) breast cancer cases due to inherited factors – BRCA1: mutations found in 80-90% of families with both breast and ovarian cancer – BRCA2: mutations mainly in male breast cancer familiesSudden cardiac death (SCD) Alzheimer’s disease Affects 5% of people >65 years and 20% of people over 80 has familial (early-onset) or sporadic (late-onset) forms, although pathologically both are similar Aetiology of sporadic forms unknown familial AD – mutations in APP, presenilin-1 and 2 Sporadic AD – strong association with APOe4, Apolipoprotein e4, which affects age of onset rather than susceptibility 3 major alleles (APO E2, E3, and E4) Position 112 158 ApoE2 Cys Cys ApoE3 Arg Cys Sudden cardiac death (SCD) ApoE4 Arg Arg Epigenetics – differential imprinting Prader-Willi syndrome failure to thrive during infancy, hyperphagia and obesity during early childhood, mental retardation, and behavioural problems molecular defect involves a ~2 Mb imprinted domain at 15q11–q13 that contains both paternally and maternally expressed genes Angelman syndrome births and characteristics include mental retardation, speech impairment and behavioural abnormalities AS defect lies within the imprinted domain at 15q11–q13 Genetic causes Prader-Willi syndrome Angelman syndrome 70% have a deletion of the PWS/AS region on their paternal chromosome 15 70% have a deletion of the PWS/AS region on their maternal chromosome 15 25% have maternal uniparental disomy for chromosome 15 (the individual inherited both chromosomes from the mother, and none from the father) 7% have paternal uniparental disomy for chromosome 15 (the individual inherited both chromosomes from the father, and none from the mother) 5% have an imprinting defect <1% have a chromosome abnormality including the PWS/AS region 3% have an imprinting defect 11% have a mutation in UBE3A 1% have a chromosome rearrangement 11% have a unknown genetic cause Reading HMG3 by T Strachan & AP Read : Chapter 14 AND/OR Genetics by Hartwell (2e) chapter 11 References on Cystic fibrosis: Science (1989) vol 245 pg 1059 by JM Rommens et al (CF mapping) J. Biol Chem (2000) vol 275 No 6 pp 3729 by MH Akabas (CFTR) Optional Reading on Molecular medicine Nature (May2004) Vol 429 Insight series • human genomics and medicine pp439 (editorial) • Mapping complex disease loci in whole genome studies by CS Carlson et al pp446-452